2021
DOI: 10.1080/14786419.2020.1869968
|View full text |Cite
|
Sign up to set email alerts
|

Isolation and neuroprotective prospective of novel bioactive compound “3-(3,4-dimethoxyphenyl)-1-(4-methoxyphenyl) prop-2-en-1-one” against ketamine-induced cognitive deficits in schizophrenia: an experimental study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…A new flavonoid compound, 3‐(3,4‐dimethoxyphenyl)‐1‐(4‐methoxyphenyl)prop‐2‐en‐1‐one isolated from methanolic extract of seeds showed significant neuroprotective effect against ketamine‐induced cognitive deficits in rats. Ketamine‐affected cholinergic variations in different parts of the brain were retained to normal levels after treating with this compound on par with clozapine (standard drug) (Chintha & Wudayagiri, 2021). Investigations conducted against methyl mercury caused nerve toxicity in the cerebellum of male Wister rats revealed an increased mitochondrial electron transport chain activity, lessened release of cytochrome C and higher rate caspase 3 mRNA expressions upon treatment of the subject with C. paniculatus seed ethanolic extract.…”
Section: Central Nervous System Activitiesmentioning
confidence: 99%
“…A new flavonoid compound, 3‐(3,4‐dimethoxyphenyl)‐1‐(4‐methoxyphenyl)prop‐2‐en‐1‐one isolated from methanolic extract of seeds showed significant neuroprotective effect against ketamine‐induced cognitive deficits in rats. Ketamine‐affected cholinergic variations in different parts of the brain were retained to normal levels after treating with this compound on par with clozapine (standard drug) (Chintha & Wudayagiri, 2021). Investigations conducted against methyl mercury caused nerve toxicity in the cerebellum of male Wister rats revealed an increased mitochondrial electron transport chain activity, lessened release of cytochrome C and higher rate caspase 3 mRNA expressions upon treatment of the subject with C. paniculatus seed ethanolic extract.…”
Section: Central Nervous System Activitiesmentioning
confidence: 99%
“…The bioactive principle used in the current study for the determination of neuroprotective activity was previously isolated, characterized from the seeds of the medicinal plant Celastrus paniculatus and was reported for in vivo neuroprotective activity with particular reference to the cholinergic, dopaminergic, glutamatergic, and ATPase systems [15][16][17][18]. PC 12, a cell line derived from pheochromocytomas of the rat adrenal medulla, has an embryonic origin from the neural crest, has a mixture of neuroblastic properties, and has been reported in the study of expressions of catecholamines, dopamine, and norepinephrine.…”
Section: Source Of Plant Constituent and Cell Linesmentioning
confidence: 99%
“…Several research groups, such as Zhanget et al (2004), Bigoniya and Rana (2005), and Kothari et al (2010), identified and reported several medicinal plants exhibiting antipsychotic and antidepressant activities using in vivo models [12][13][14]. In view of the relative promising activity of the flavonoid group of molecules from medicinal plants as potent neuroprotective agents, in our previous study, we isolated and characterized a bioactive compound, 3-(3,4-dimethoxy phenyl)-1-(4-methoxy phenyl)prop-2-en-1-one (structural analog of flavonoid), from the medicinal plant Celastrus paniculatus (CP) and reported its neuroprotective activity in vivo, with particular reference to the cholinergic, dopaminergic, glutamatergic, and ATPase systems [15][16][17][18]. In continuation of the earlier studies, the current study aimed to determine the in vitro neuroprotective activity of this bioactive compound against ketamine-induced neurotoxicity in PC 12 cell lines.…”
Section: Introductionmentioning
confidence: 99%